Henry Schein, Inc. HSIC registered adjusted earnings per share (EPS) of $1.15 in the first quarter of 2025, up 4.5% from the ...

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dental and medical products company Henry Schein (NASDAQ:HSIC) in Q1 CY2025, with sales flat year on year at $3.17 billion.

In a landmark collaboration aimed at improving early disease detection and enhancing community resilience, the Antigua and ...

Globally, measles is on the rise across the U.S., Canada, Mexico, South America and parts of Europe. In 2025, North and South ...

However, the model's predictive power is significant for ... or 5 (Strong Sell). For Henry Schein, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts ...

Cencora is an established healthcare distributor, which can capture market demand, and is a proven dividend grower. Learn why ...

If children who missed vaccines due to the pandemic do not receive catch-up vaccinations, and vaccine hesitancy continues at current rates, the study found, then 21% of U.S. children – about 15 ...

Henry Schein, Inc. HSIC registered adjusted earnings ... This was almost in line with our model’s projection. Within this, Global Dental Distribution merchandise sales for the quarter rose ...